TEVA · Teva Pharmaceutical Industries Ltd · Debt
Market Cap
$45.92B
Shares
1.17B
Volume · Oct 23
5.6M
Avg daily vol (3M)
5.69M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current debt and lease obligations | 2026-06-30 | USD 4,500,000,000 | 10-Q filed 2026-07-29 |
| Current portion of long-term debt | 2026-06-30 | USD 4,500,000,000 | 10-Q filed 2026-07-29 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 282,000,000 | 10-Q filed 2026-07-29 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
818686
CUSIP
M8769Q102
13F (30d)
114 filings
102 filers
Visit website
Investor relations